共 541 条
[1]
Ferlay J(2010)Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int J Cancer 127 2893-2917
[2]
Shin HR(2009)Improving survival for stage IV non-small cell lung cancer: a surveillance, epidemiology, and end results survey from 1990 to 2005 J Thorac Oncol 4 1524-1529
[3]
Bray F(2015)Nanotechnology-based inhalation treatments for lung cancer: state of the art Nanotechnol Sci Appl 8 55-66
[4]
Forman D(2003)Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications Br J Clin Pharmacol 56 588-599
[5]
Mathers C(2014)Emerging inhalation aerosol devices and strategies: where are we headed? Adv Drug Deliv Rev 75 3-17
[6]
Parkin DM(2018)Inhalation delivery of topotecan is superior to intravenous exposure for suppressing lung cancer in a preclinical model Drug Deliv 25 1127-1136
[7]
Morgensztern D(2004)The lungs as a portal of entry for systemic drug delivery Proc Am Thorac Soc 1 338-344
[8]
Waqar S(2008)Aerosolized chemotherapy J Aerosol Med Pulm Drug Deliv 21 61-70
[9]
Subramanian J(2007)Nanoparticles for drug delivery to the lungs Trends Biotechnol 25 563-570
[10]
Gao F(2016)Perspective on nanoparticle technology for biomedical use Curr Pharm Des 22 2481-2490